MedPath

Effect Time of Administration of Clomiphene citrate on the Fertility of patients with Polycystic Ovary Syndrome

Not Applicable
Conditions
polycystic ovarian syndrome.
polycystic ovarian syndrome
Registration Number
IRCT2016052125292N4
Lead Sponsor
Vice chancellor for research of Babol University of Medical Science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
115
Inclusion Criteria

Patients with Polycystic Ovary Syndrome and undergoing Intrauterine insemination; Age 18 to 35 years; duration of infertility less than 5 years; normal hysterosalpingography and normal spermogram; No previous use of gonadotropin
Exclusion criteria: Follicle-stimulating hormone base of more than or equal to 14; Ovarian pathology; There is an ovary; Absence due to male factor infertility; endometriosis; tubal obstruction

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
On Follicular Growth, Endometrial Thickness and Ovulation. Timepoint: 11 day menstrual cycle. Method of measurement: With transvaginal sonography in millimeters.
Secondary Outcome Measures
NameTimeMethod
Pregnancy. Timepoint: 16 days after injection of Human Chorionic Gonadotropin. Method of measurement: B-Human Chorionic Gonadotropin test serum.
© Copyright 2025. All Rights Reserved by MedPath